TDF Global Fund Annual Report 2004-2005

TDF Annual Report 2004-2005

IJTLD, Vol. 9, No. 11, (November) 2005, Supplement 1: S291 (pdf format)

Quelapio, MID, Auer, C, Orillaza, R, Mira, N, Belen, V, Egos, G and Tupasi, TE, “Mainstreaming DOTS-Plus to DOTS: when is culture indicated in DOTS?,” The International Journal of Tuberculosis and Lung Disease, Vol. 9, No. 11, (November) 2005, Supplement 1: S291.

IJTLD, Vol. 9, No. 11, (November) 2005, Supplement 1: S261 (pdf format)

Gler, MTG, Orillaza, RB, Macalintal, LM, Belen, VA, Raymond, L, Mira, NR, Quelapio, MID and Tupasi, TE, “Detection of MDR-TB in chronic cases of pulmonary tuberculosis in Makati, Philippines,” The International Journal of Tuberculosis and Lung Disease, Vol. 9, No. 11, (November) 2005, Supplement 1: S261.

IJTLD, Vol. 9, No. 11, (November) 2005, Supplement 1: S260 (pdf format)

Quelapio, MID, Belen, V, Lagahid, J, Medina, A, Dimatatac, E and Tupasi, TE, “What happens to DOTS treatment failures if DOTS-Plus is not available?,” The International Journal of Tuberculosis and Lung Disease, Vol. 9, No. 11, (November) 2005, Supplement 1: S260.

IJTLD, Vol. 9, No. 11, (November) 2005, Supplement 1: S245 (pdf format)

Auer, C, Lagahid, J, Roa, C, Ang, C, Van Deun, A, Tanner, M, Weiss, MG, Quelapio I, Orillaza, R, Mira, N, Belen, V and Tupasi, TE, “Smear positivity at two/three months of treatment: does it indicate MDR-TB?,” The International Journal of Tuberculosis and Lung Disease, Vol. 9, No. 11, (November) 2005, Supplement 1: S245.

IJTLD, Vol. 9, No. 11, (November) 2005, Supplement 1: S68 (pdf format)

Quelapio, MID, Orillaza, RB, Mira, NR, Belen, VA, Salud, ML, Macalintal, L, Raymond, L and Tupasi, TE, “Contribution of a PPMD clinic to case detection in its catchment area,” The International Journal of Tuberculosis and Lung Disease, Vol. 9, No. 11, (November) 2005, Supplement 1: S68.

IJTLD, Vol. 9, No. 11, (November) 2005, Supplement 1: S306 (pdf format)

Auer, C, Lagahid, J, Roa, C, Ang, C, Montejo, L, Van Deun, A, Weiss, MG and Tanner, M, “Re-treatment TB patients treated in a public DOTS programme: who among them is likely to have poor treatment outcome?,” The International Journal of Tuberculosis and Lung Disease, Vol. 9, No. 11, (November) 2005, Supplement 1: S306.